Voyager Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
3.17
-0.26
(-7.58%)
Volume:
756,118
52 week range:
2.75 - 9.55
Market Cap:
175.417M
Company Description:
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease.